Skip to content
DataLookout
Menu

Alliance for Clinical Trials in Oncology clinical trial pipeline

Get alerts when Alliance for Clinical Trials in Oncology's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20

What changed in the last 30 days

18 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 15 with minor changes only.

  1. Notable: Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects Primary and study completion pushed from Oct 1, 2026 to Oct 1, 2027 Alliance for Clinical Trials in OncologyNot specified NCT04242095
  2. Minor: HOPE · High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer Trial sites expanded: 212 → 216 locations Alliance for Clinical Trials in OncologyPhase 3 NCT06992427
  3. Minor: Collecting Blood Samples From · and Without Cancer to Evaluate Tests for Early Cancer Detection Trial sites expanded: 747 → 751 locations Alliance for Clinical Trials in OncologyNot specified NCT05334069
  4. Minor: Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young · Cancer Trial sites expanded: 324 → 327 locations Alliance for Clinical Trials in OncologyNot applicable NCT07091617
  5. Minor: Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays Trial sites expanded: 368 → 398 locations Alliance for Clinical Trials in OncologyNot applicable NCT07283939
  6. Minor: DEFEND · Distance-Based Exercise to Preserve Function and Prevent Disability Trial sites expanded: 23 → 30 locations Alliance for Clinical Trials in OncologyNot applicable NCT07059884
  7. Minor: Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer Trial sites expanded: 152 → 177 locations Alliance for Clinical Trials in OncologyPhase 3 NCT07215910
  8. Minor: STRIKE · Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer Trial sites expanded: 425 → 429 locations Alliance for Clinical Trials in OncologyPhase 3 NCT06661720
  9. Minor: Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL Trial sites expanded: 224 → 261 locations Alliance for Clinical Trials in OncologyPhase 3 NCT07321652
  10. Minor: MFOLFIRINOX Versus mFOLFOX With or Without Nivolumab · Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma Trial sites expanded: 798 → 802 locations Alliance for Clinical Trials in OncologyPhase 3 NCT05677490
  11. Minor: Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib · Previously Untreated Mantle Cell Lymphoma Trial sites expanded: 238 → 242 locations Alliance for Clinical Trials in OncologyPhase 3 NCT05976763
  12. Minor: Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on · Advanced Prostate Cancer, RECIPROCAL Trial Trial sites expanded: 138 → 142 locations Alliance for Clinical Trials in OncologyPhase 3 NCT07200830
  13. Minor: Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment Trial sites expanded: 111 → 125 locations Alliance for Clinical Trials in OncologyPhase 2 NCT07293247
  14. Minor: Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial Trial sites expanded: 189 → 195 locations Alliance for Clinical Trials in OncologyPhase 2 NCT05673148
  15. Minor: Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib · Progressive Meningiomas Trial sites expanded: 784 → 791 locations Alliance for Clinical Trials in OncologyPhase 2 NCT02523014
  16. Minor: Family Communications After Genetic Testing Trial sites expanded: 360 → 365 locations Alliance for Clinical Trials in OncologyNot applicable NCT07143487
  17. Notable: Genetic Testing in Guiding Treatment · Brain Metastases Results posted: Oct 30, 2026 Alliance for Clinical Trials in OncologyPhase 2 NCT03994796
  18. Notable: SHARES · Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions Results posted: Oct 27, 2026 Alliance for Clinical Trials in OncologyNot applicable NCT04549571
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-22 NCT07887984 Comparing Bispecific Antibody Treatment to Autologous Stem Cell Transplant for Newly… Phase 2/3 Not Yet Recruiting

Active trials by phase

Phase 2
18
Phase 2/3
6
Phase 3
34
Not charted: 10 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 32

Get alerts when Alliance for Clinical Trials in Oncology's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free